| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Orchard Therapeutics plc (NASDAQ: ORTX)
ORTX Technical Analysis
5
| As on 9th Jun 2023 ORTX STOCK Price closed @ 4.87 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.69 & Strong Buy for SHORT-TERM with Stoploss of 1.11 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ORTXSTOCK Price
| Open | 4.97 | Change | Price | % |
| High | 5.03 | 1 Day | -0.10 | -2.01 |
| Low | 4.87 | 1 Week | -0.30 | -5.80 |
| Close | 4.87 | 1 Month | 0.09 | 1.88 |
| Volume | 38268 | 1 Year | 3.65 | 299.18 |
| 52 Week High 5.83 | 52 Week Low 0.37 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ORTX Daily Charts |
ORTX Intraday Charts |
Whats New @ Bazaartrend |
ORTX Free Analysis |
|
|
ORTX Important Levels Intraday
| RESISTANCE | 5.18 |
| RESISTANCE | 5.08 |
| RESISTANCE | 5.02 |
| RESISTANCE | 4.96 |
| SUPPORT | 4.78 |
| SUPPORT | 4.72 |
| SUPPORT | 4.66 |
| SUPPORT | 4.56 |
ORTX Forecast April 2024
| 4th UP Forecast | 6.03 |
| 3rd UP Forecast | 5.66 |
| 2nd UP Forecast | 5.43 |
| 1st UP Forecast | 5.2 |
| 1st DOWN Forecast | 4.54 |
| 2nd DOWN Forecast | 4.31 |
| 3rd DOWN Forecast | 4.08 |
| 4th DOWN Forecast | 3.71 |
ORTX Weekly Forecast
| 4th UP Forecast | 5.45 |
| 3rd UP Forecast | 5.26 |
| 2nd UP Forecast | 5.15 |
| 1st UP Forecast | 5.03 |
| 1st DOWN Forecast | 4.71 |
| 2nd DOWN Forecast | 4.59 |
| 3rd DOWN Forecast | 4.48 |
| 4th DOWN Forecast | 4.29 |
ORTX Forecast2024
| 4th UP Forecast | 15.83 |
| 3rd UP Forecast | 12.32 |
| 2nd UP Forecast | 10.14 |
| 1st UP Forecast | 7.97 |
| 1st DOWN Forecast | 1.77 |
| 2nd DOWN Forecast | -0.4 |
| 3rd DOWN Forecast | -2.58 |
| 4th DOWN Forecast | -6.09 |
Orchard Therapeutics plc ( NASDAQ USA Symbol : ORTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ORTX Business Profile
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the treatment of adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company's clinical development products comprise OTL-101 for the treatment of ADA-SCID; OTL-200 to treat metachromatic leukodystrophy; OTL-103 for the treatment of Wiskott-Aldrich syndrome; OTL-102 for X-linked chronic granulomatous disease; and OTL-300 for transfusion-dependent beta-thalassemia. Its preclinical programs include OTL-203 for mucopolysaccharidosis type I, OTL-201 for mucopolysaccharidosis type MPS-IIIA, and OTL-202 for mucopolysaccharidosis type IIIB. The company has a strategic collaboration agreement with Pharming Group N.V. for research, development, manufacturing, and commercialization of OTL-105, an investigational ex vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. The company was formerly known as Orchard Rx Limited. Orchard Therapeutics plc was founded in 2015 and is headquartered in London, the United Kingdom. Address: 108 Cannon Street, London, United Kingdom, EC4N 6EU
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service